65 results about "Breathing treatments" patented technology

A device and method is provided for electrically stimulating the diaphragm to control breathing while inhibiting respiratory drive. A stimulation phase is identified. The stimulation phase is a period of time within the breathing cycle in which stimulation will inhibit respiratory drive. The respiratory drive inhibition may be used in a number of applications including but not limited to: improving or remodeling the heart in heart failure patients, treating apnea, chronic obstructive pulmonary disorder (COPD), and hypertension.

A continuous high-frequency oscillation breathing device delivers therapy during both inhalation and exhalation in order to assist in clearing secretions from the lungs. A fixed shrouded-venturi patient interface circuit is combined with medicated aerosol to deliver continuous high-frequency oscillation therapy. Fixed open apertures in the patient interface circuit allow ingress and egress of flow, and are calibrated to allow exhalation and prevent stacking of successive breaths.

An external respiratory therapy device incorporates sensors that may be used to sense physiological conditions or parameters associated with pulmonary disease. The sensed conditions may be used to detect and/or to assess a presence of various types of pulmonary diseases. The assessment of the pulmonary disease may be utilized to control a drug therapy delivered to the patient to treat the pulmonary disease.

A respiratory therapy device including a housing and an interrupter valve assembly. The housing is sized for handling by a patient and defines a patient breathing passage extending from a patient end and through which a patient inhales and exhales air. The interrupter valve assembly is carried by the housing and includes a control port, a valve body, and a drive mechanism. Expiratory airflow is released from the patient breathing passage through the control port. The valve body is sized to at least partially obstruct fluid flow through the control port. The drive mechanism moves the valve body relative to the control port in response to the expiratory airflow such that the valve body repeatedly transitions between a position of maximum obstruction and a position of minimum obstruction relative to the control port to create an oscillatory positive expiratory pressure effect.

Methods and systems for diagnosing disorders, including, for example, disordered breathing, involve sensing one or more of a blood chemistry parameter and/or an expired gas parameter, such as expired respiratory gas concentration, blood gas concentration, and blood pH. Diagnosis of the disorder may be performed by a medical device, such as a respiratory therapy device or a cardiac therapy device, based on implantably detected blood gas/pH concentration/level or externally detected expired respiratory gas concentration. Cardiac and respiratory therapies for addressing the disorder may be adjusted based on the detected parameters.

A flow regulating valve for a respiratory treatment system is disclosed, as well as a vent arrangement comprising the flow regulating valve. The flow regulating valve may include an inlet, an outlet, and a variable conduit in fluid communication with the inlet and the outlet. The variable conduit may include a movable portion that may move to vary an impedance of the variable conduit, thereby regulating a flow rate of the air travelling through the variable conduit. Advantageously, the flow regulating valve may thus reduce wastage of air (e.g. humidified air) that is exhausted from a respiratory treatment system, while maintaining sufficient washout of air.

A method of providing a combination lung treatment therapy that is substantially uninterrupted between providing continuous positive airway pressure therapy and high-frequency therapy is disclosed. The present invention combines multiple respiratory therapies in order to facilitate the prevention and treatment of certain pulmonary diseases. The present invention also discloses a method of providing a combination lung treatment therapy that is substantially uninterrupted between providing medicated continuous positive airway pressure therapy and medicated high-frequency therapy is disclosed.

Automated methods provide a ventilation sufficiency assessment to evaluate patient respiration. In some embodiments, a ventilation histogram maybe determined from a measure of patient respiratory flow. Based on the histogram or associated ventilation data, hypoventilation or hyperventilation occurrences may be detected. For example, a kurtosis index and/or skewness index may be calculated with the data associated with the ventilation histogram and may be evaluated as an indication of hypoventilation or hyperventilation. An assessment of the number of peaks and other features of the ventilation histogram, such as in the case of a bimodal ventilation histogram, may be implemented to detect an occurrence of ventilation insufficiency or sufficiency. The detection methodologies may be implemented by a specific purpose computer, a detection device that measures a respiratory airflow or a respiratory treatment apparatus that provides a respiratory treatment regime based on the detected ventilation sufficiency.

The invention discloses an inhalation drug administration device for the respiratory medicine department. The inhalation drug administration device includes a drug administration shell, an evaporator, a ball-shaped spray head, a one-way air inlet valve, an air jet device, an oxygen hose, support legs, a liquid discharging valve, a first filtration sleeve, a liquid drawing hose, a liquid jet pump, an atomization spray head, a water adding pipeline, a water adding cover, a first seal mat, a pot, a second seal mat, an upper cover, a one-way air discharging valve, a valve, a drug administration hose, a communicated hose, a liquid discharging hole, a hood and a quantitative drug adding device. The inhalation drug administration device for the respiratory medicine department has the advantages of being simple and reasonable in structure, low in production cost and convenient to mount; when the inhalation drug administration device is in use, firstly, a moderate amount of purified water is added into the drug administration shell through the water adding pipeline, then, a push-pull rod is pulled upwards, and medical liquid in a drug storing box is sucked into a measuring cylinder through a piston; through scale lines arranged on the push-pull rod, it is convenient to observe the mount of the medical liquid sucked in; then, the push-pull rod is pressed down, so that the medical liquid enters the drug administration shell; finally, the evaporator is started, so that the medical liquid and wet gas enter together and are output to patients through the ball-shaped spray head to conduct respiratory therapy.

The invention relates to a breathing device adopting a boiled water wetted asthma drug and belongs to the technical field of medical instruments. According to the technical scheme, the breathing device adopting the boiled water wetted asthma drug comprises an oxygen production device body, wherein an oxygen production tank seat groove is formed in the oxygen production device body, an oxygen production tank is arranged in the oxygen production tank seat groove, a cover is arranged on the oxygen production tank, a pressure gauge dial is arranged on the front side of the oxygen production tank, a pressure pointer is arranged in the pressure gauge dial, an oxygen outlet is formed in the right side of the oxygen production seat groove, and an oxygen receiving pipe is arranged in the oxygen outlet and connected with an oxygen conveying pipe connected with a mixing distributor, a drug steam conveying pipe is arranged on the left side of the oxygen conveying pipe, an adjusting transit port is formed in the right side of the mixing distributor, an adjusting and distributing knob is arranged in the adjusting transit port, and the lower side of the mixing distributor is connected with branch pipes. The device has complete functions, is convenient to use and is time-saving, labor-saving, scientific, convenient, safe and efficient when used for auxiliary breathing treatment on a patient through the boiled water wetted drug, and the work difficulty of medical workers is reduced.